HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,747,000 Value ($000) $6,218 Avg Close — Range —
Q3 2025
Shares 29,170,000 Value ($000) $33,480 Avg Close — Range —
Q2 2025
Shares 29,222,000 Value ($000) $29,101 Avg Close — Range —
Q1 2025
Shares 33,640,000 Value ($000) $35,728 Avg Close — Range —
Q4 2024
Shares 29,164,000 Value ($000) $27,864 Avg Close — Range —
Q3 2024
Shares 29,773,000 Value ($000) $29,874 Avg Close — Range —
Q2 2024
Shares 4,580,000 Value ($000) $4,375 Avg Close — Range —
Q1 2024
Shares 4,580,000 Value ($000) $4,064 Avg Close — Range —
Q4 2023
Shares 4,580,000 Value ($000) $3,959 Avg Close — Range —
Q3 2023
Shares 4,580,000 Value ($000) $3,879 Avg Close — Range —
Q2 2023
Shares 7,079,000 Value ($000) $5,900 Avg Close — Range —
Q1 2023
Shares 7,210,000 Value ($000) $6,117 Avg Close — Range —
Q4 2022
Shares 5,930,000 Value ($000) $5,781 Avg Close — Range —
Q3 2022
Shares 23,808,000 Value ($000) $20,236 Avg Close — Range —
Q2 2022
Shares 43,634,000 Value ($000) $38,575 Avg Close — Range —
Q1 2022
Shares 43,624,000 Value ($000) $38,410 Avg Close — Range —